ZNF84 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.205400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.940400E-01
Normal-vs-Stage2
3.500400E-02
Normal-vs-Stage3
1.275780E-01
Normal-vs-Stage4
6.020000E-01
Stage1-vs-Stage2
2.659600E-01
Stage1-vs-Stage3
9.252200E-02
Stage1-vs-Stage4
6.884800E-01
Stage2-vs-Stage3
9.094100E-02
Stage2-vs-Stage4
1.685950E-01
Stage3-vs-Stage4
4.573900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.588960E-01
Normal-vs-AfricanAmerican
5.474300E-02
Normal-vs-Asian
1.750030E-02
Caucasian-vs-AfricanAmerican
3.481600E-01
Caucasian-vs-Asian
6.067700E-02
AfricanAmerican-vs-Asian
5.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.175990E-01
Normal-vs-Female
1.432810E-01
Male-vs-Female
8.719800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.267400E-01
Normal-vs-Age(41-60Yrs)
2.387000E-01
Normal-vs-Age(61-80Yrs)
5.912200E-02
Normal-vs-Age(81-100Yrs)
5.688000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.845000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.997600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.017400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.668500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.762600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.954200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.358200E-02
Normal-vs-Daily Drinker
2.072600E-01
Normal-vs-Weekly Drinker
3.372200E-02
Normal-vs-Occasional Drinker
1.611590E-01
Normal-vs-Social Drinker
3.924000E-01
Non Drinker-vs-Daily Drinker
6.305400E-01
Non Drinker-vs-Weekly Drinker
7.686200E-01
Non Drinker-vs-Occasional Drinker
2.501000E-01
Non Drinker-vs-Social Drinker
1.005440E-01
Daily Drinker-vs-Weekly Drinker
5.514000E-01
Daily Drinker-vs-Occasional Drinker
6.480000E-01
Daily Drinker-vs-Social Drinker
3.662200E-01
Weekly Drinker-vs-Occasional Drinker
2.004200E-01
Weekly Drinker-vs-Social Drinker
1.081220E-01
Occasional Drinker-vs-Social Drinker
5.561800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.871020E-01
Normal-vs-Grade 2
1.583980E-02
Normal-vs-Grade 3
2.848200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.044390E-01
Grade 1-vs-Grade 3
1.958580E-01
Grade 1-vs-Grade 4
1.871020E-01
Grade 2-vs-Grade 3
4.292400E-01
Grade 2-vs-Grade 4
1.583980E-02
Grade 3-vs-Grade 4
2.848200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.890430E-02
Normal-vs-NonDiabetic
1.862000E-01
Diabetic-vs-NonDiabetic
1.224210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.682110E-02
Normal-vs-NoPancreatitis
1.122200E-01
Pancreatitis-vs-NoPancreatitis
2.686200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.087000E-01
Normal-vs-N1
4.502200E-02
N0-vs-N1
5.479000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.881600E-01
Normal-vs-TP53-NonMutant
5.315800E-01
TP53-Mutant-vs-TP53-NonMutant
8.664300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
